Publication | Closed Access

Characterization and optimization of co-delivery Farnesol-Gingerol Niosomal formulation to enhance anticancer activities against breast cancer cells

NanomedicineNanotherapeuticsAnticancer ActivitiesPolymer-drug ConjugateMedicineBreast Cancer CellsNano-drug DeliveryTumor TargetingAnti-cancer AgentPharmacologyRadiation OncologyDrug Discovery